IPC Research
Waukesha, Wisconsin, United States
Doctor in Waukesha, Wisconsin
2717 N Grandview Blvd, Waukesha, WI 53188
About IPC Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
ACADIA Pharmaceuticals Inc.
3
Otsuka Pharmaceutical Development & Commercialization, Inc.
3
FUJIFILM Toyama Chemical Co., Ltd.
1
Sanofi
1
Clinical Trials at IPC Research
During the past decade, IPC Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
2003-11-01
2007-10-01
Completed
1,306
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
2008-04-01
2011-06-01
Completed
373
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type
2015-11-11
2019-09-09
Completed
522
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2015-12-01
2025-07-01
Recruiting
1,200
Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)
2016-12-01
2018-10-01
Completed
207
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2017-10-13
2024-03-01
Recruiting
550
Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
2019-04-25
2020-05-29
Completed
298
Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
2019-06-06
2021-02-22
Terminated
235
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at IPC Research
According to Clinical.Site data, the most researched conditions in "IPC Research" are
"Adjunctive Treatment of Major Depressive Disorder" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials), "Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "IPC Research" in a lesser frequency.
Clinical Trials Intervention Types at IPC Research
Most popular intervention types in "IPC Research" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Pimavanserin" (3 trials), "AVP-786" (2 trials), "AVP-786-18" (1 trials) and "AVP-786-28" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IPC Research
The vast majority of trials in "IPC Research" are
8 trials for "All" genders.
Clinical Trials Status at IPC Research
Currently, there are NaN active trials in "IPC Research".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in IPC Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in IPC Research, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".